X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5548) 5548
Book Review (1601) 1601
Publication (496) 496
Book Chapter (66) 66
Conference Proceeding (13) 13
Dissertation (9) 9
Government Document (6) 6
Magazine Article (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3975) 3975
humans (3666) 3666
prostate cancer (3581) 3581
male (3543) 3543
androgen deprivation therapy (2313) 2313
oncology (2275) 2275
aged (1700) 1700
androgen-deprivation therapy (1687) 1687
urology & nephrology (1680) 1680
cancer (1375) 1375
prostatic neoplasms - drug therapy (1366) 1366
middle aged (1359) 1359
androgen deprivation (1342) 1342
radical prostatectomy (1233) 1233
prostatic neoplasms - pathology (1223) 1223
care and treatment (1179) 1179
radiotherapy (1146) 1146
men (1114) 1114
androgen antagonists - therapeutic use (1017) 1017
prostatic neoplasms - therapy (798) 798
treatment outcome (798) 798
aged, 80 and over (757) 757
prostatic neoplasms - radiotherapy (737) 737
risk factors (724) 724
radiation-therapy (670) 670
research (667) 667
carcinoma (651) 651
survival (645) 645
prostate-specific antigen - blood (636) 636
health aspects (631) 631
prostate (629) 629
androgens (621) 621
quality-of-life (593) 593
metastasis (585) 585
testosterone (526) 526
prostatic neoplasms - mortality (522) 522
urology (520) 520
antineoplastic agents, hormonal - therapeutic use (505) 505
analysis (504) 504
prognosis (500) 500
risk (499) 499
prostatectomy (492) 492
randomized controlled-trial (484) 484
prostatic neoplasms - surgery (473) 473
prostatic neoplasms - blood (463) 463
radiology, nuclear medicine & medical imaging (457) 457
retrospective studies (439) 439
quality of life (425) 425
chemotherapy (418) 418
prostate-cancer (408) 408
mortality (406) 406
endocrinology & metabolism (405) 405
androgen antagonists - adverse effects (404) 404
neoplasm staging (402) 402
hematology, oncology and palliative medicine (385) 385
osteoporosis (378) 378
animals (376) 376
medicine & public health (372) 372
radiation therapy (365) 365
therapy (361) 361
castration (358) 358
suppression (357) 357
follow-up studies (353) 353
article (333) 333
abridged index medicus (329) 329
prostatic neoplasms - metabolism (326) 326
time factors (319) 319
adult (318) 318
combined modality therapy (318) 318
disease-free survival (318) 318
prostate-specific antigen (314) 314
disease progression (313) 313
orchiectomy (307) 307
brachytherapy (302) 302
external-beam radiotherapy (302) 302
breast-cancer (299) 299
trial (292) 292
surgery (290) 290
zoledronic acid (287) 287
prostatic neoplasms - diagnosis (286) 286
cancer patients (284) 284
diagnosis (284) 284
patients (279) 279
phase-iii trial (278) 278
docetaxel (275) 275
radiation (273) 273
cancer therapies (264) 264
oncology, experimental (260) 260
development and progression (254) 254
patient outcomes (250) 250
female (249) 249
prostatic neoplasms (249) 249
hormonal-therapy (241) 241
progression (239) 239
bone-mineral density (234) 234
follow-up (229) 229
review (227) 227
antineoplastic agents - therapeutic use (226) 226
clinical trials (226) 226
risk assessment (226) 226
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5206) 5206
German (155) 155
French (151) 151
Spanish (81) 81
Japanese (10) 10
Russian (6) 6
Polish (4) 4
Czech (3) 3
Chinese (2) 2
Dutch (2) 2
Portuguese (2) 2
Slovak (2) 2
Turkish (2) 2
Belarusian (1) 1
Croatian (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2019, Volume 17, Issue 5, pp. 583 - 586
Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic... 
ANDROGEN DEPRIVATION | ONCOLOGY | INTERMITTENT
Journal Article
Medicine and Science in Sports and Exercise, ISSN 0195-9131, 12/2006, Volume 38, Issue 12, pp. 2045 - 2052
Journal Article
Cancer Research, ISSN 0008-5472, 11/2018, Volume 78, Issue 22, pp. 6354 - 6362
The standard treatment for metastatic prostate cancer, androgen deprivation therapy (ADT), is designed to suppress androgen receptor (AR) activity. However,... 
TUMOR-SUPPRESSOR | ANDROGEN-DEPRIVATION | INHIBITION | GENE | ONCOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2018, Volume 36, Issue 11, pp. 1080 - 1087
PurposeDocetaxel added to androgen-deprivation therapy (ADT) significantly increases the longevity of some patients with metastatic hormone-sensitive prostate... 
ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | MEN | FLUTAMIDE | DNA-REPAIR | CASTRATION | DOCETAXEL | ORIGINAL REPORTS
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 05/2019, Volume 20, Issue 5, pp. 686 - 700
Background In the interim analyses of the LATITUDE study, the addition of abiraterone acetate plus prednisone to androgen deprivation therapy (ADT) led to a... 
ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | GUIDELINES | MEN | DOCETAXEL | CHEMOTHERAPY
Journal Article
Annals of Oncology, ISSN 0923-7534, 2012, Volume 23, Issue 6, pp. 1542 - 1549
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 05/2019, Volume 104, Issue 1, pp. 33 - 35
Journal Article
EUROPEAN UROLOGY, ISSN 0302-2838, 06/2019, Volume 75, Issue 6, pp. 948 - 949
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 5, pp. 1432 - 1438
To analyze dosimetric outcomes after permanent brachytherapy for men with low-risk and “low-tier” intermediate-risk prostate cancer and explore the... 
Brachytherapy | Dosimetry | Androgen deprivation | Prostate cancer
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 02/2015, Volume 42, Issue 2, pp. 197 - 209
Purpose Since the introduction of positron emission tomography (PET) imaging with Ga-68-PSMA-HBED-CC (-(68)GaDKFZ-PSMA-11), this method has been regarded as a... 
TOMOGRAPHY | MEMBRANE ANTIGEN-EXPRESSION | FECH | INITIAL-EXPERIENCE | PRIMARY TUMOR | ADENOCARCINOMA | RECEPTOR | FMCH | LYMPH-NODE METASTASES | PSMA | ANDROGEN-DEPRIVATION | THERAPY | PET/MRI | PET/CT | Prostate cancer | Positron emission tomography | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2348 - 2349
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2349 - 2349
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 01/2016, Volume 374, Issue 3, pp. 287 - 287
Journal Article
MOLECULAR CANCER THERAPEUTICS, ISSN 1535-7163, 03/2019, Volume 18, Issue 3, pp. 726 - 729
There are many treatment options available for men with metastatic castration-resistant prostate cancer (mCRPC). Yet, biomarkers predictive of differential... 
ANDROGEN-DEPRIVATION THERAPY | STATIN USE | TIME | ONCOLOGY | ASSOCIATION | PROGRESSION
Journal Article
JOURNAL OF UROLOGY, ISSN 0022-5347, 11/2017, Volume 198, Issue 5, pp. 1068 - 1068
Journal Article
Aging Male, ISSN 1368-5538, 2019, pp. 1 - 6
In this study, we administered a questionnaire to consecutive prostate cancer patients who received androgen deprivation therapy (ADT) for understanding the... 
androgen deprivation therapy | Prostate cancer | depression
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 06/2015, Volume 16, Issue 6, pp. E258 - E259
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.